malaria vaccine


Wit the landmark moment in the world's tight against malaria.Results from a major trial of is 460 African children released early last month, showed that the RTS,S vaccine created by glaxasmithleline (ask) has reduced the risk of malaria by 55% in children aged between 5-17.
This came as good news since many children in Kenya and Western Kenya died of malaria and had high infections of malaria compared to other parts of the country.Malaria being one of the continents most debilitating diseases it came as good to the Western Kenya people since the vaccine would see the cases of malaria infection be a thing of the past.

Glaxosmithkline gave free drugs to the villages in western Kenya with assistance that a vaccine would be found sooner than later

Location: Bukhungu, Kakamega, Kenya